TR199501542A2 - Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari. - Google Patents

Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari.

Info

Publication number
TR199501542A2
TR199501542A2 TR95/01542A TR9501542A TR199501542A2 TR 199501542 A2 TR199501542 A2 TR 199501542A2 TR 95/01542 A TR95/01542 A TR 95/01542A TR 9501542 A TR9501542 A TR 9501542A TR 199501542 A2 TR199501542 A2 TR 199501542A2
Authority
TR
Turkey
Prior art keywords
monoclonal antibody
antibody fragments
immune activity
immune
activity
Prior art date
Application number
TR95/01542A
Other languages
English (en)
Inventor
Zoltan Nagy
Damir Vidovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of TR199501542A2 publication Critical patent/TR199501542A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TR95/01542A 1994-12-07 1995-12-07 Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari. TR199501542A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35091594A 1994-12-07 1994-12-07

Publications (1)

Publication Number Publication Date
TR199501542A2 true TR199501542A2 (tr) 1996-07-21

Family

ID=23378740

Family Applications (1)

Application Number Title Priority Date Filing Date
TR95/01542A TR199501542A2 (tr) 1994-12-07 1995-12-07 Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari.

Country Status (19)

Country Link
EP (1) EP0787151A1 (tr)
JP (1) JP2001506122A (tr)
CN (1) CN1168679A (tr)
AR (1) AR002005A1 (tr)
AU (1) AU4256096A (tr)
BR (1) BR9509902A (tr)
CA (1) CA2206471A1 (tr)
CO (1) CO4480041A1 (tr)
CZ (1) CZ172497A3 (tr)
FI (1) FI972430A0 (tr)
HU (1) HUT77342A (tr)
IL (1) IL116228A0 (tr)
MA (1) MA23739A1 (tr)
NO (1) NO972522L (tr)
PE (1) PE52996A1 (tr)
PL (1) PL320610A1 (tr)
TR (1) TR199501542A2 (tr)
WO (1) WO1996017874A1 (tr)
ZA (1) ZA9510195B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893507A1 (en) * 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
WO2000012560A1 (en) 1998-08-28 2000-03-09 Dendreon Corporation Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
EP1156060B1 (en) * 2000-05-12 2007-06-27 GPC Biotech AG Human peptides/proteins causing or leading to the killing of cells including lymphoid tumor cells
US7521047B2 (en) 2000-05-12 2009-04-21 Gpc Biotech Ag Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
EP1156062A1 (en) * 2000-05-12 2001-11-21 GPC Biotech AG Immunomodulatory human MHC class II antigen-binding peptides/proteins
WO2003047623A1 (en) 2001-10-11 2003-06-12 Protein Design Labs Inc. Treatment of prostate cancer by inhibitors of ncam2
JP3665324B2 (ja) 2001-10-15 2005-06-29 麒麟麦酒株式会社 抗ｈｌａ−ｄｒ抗体
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
EP2552483A4 (en) * 2010-04-01 2013-09-25 Immunomedics Inc USE OF ANTIBODIES TO REDUCE THE NUMBER OF CELLS CONTAINING ANTIGENS AND DENDRITIC CELLS
KR102647825B1 (ko) * 2021-07-22 2024-03-14 서울대학교산학협력단 항-hla-dp 단클론 항체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3269354D1 (en) * 1981-06-25 1986-04-03 Univ Leland Stanford Junior Allele specific immunotherapeutic method and dosage form
CA2070182C (en) * 1989-12-27 2002-12-24 John Ghrayeb Chimeric immunoglobulin for cd4 receptors
ATE237638T1 (de) * 1991-07-25 2003-05-15 Idec Pharma Corp Rekombinante antikörper zur humanen therapie

Also Published As

Publication number Publication date
FI972430A (fi) 1997-06-06
CA2206471A1 (en) 1996-06-13
NO972522D0 (no) 1997-06-03
AR002005A1 (es) 1998-01-07
HUT77342A (hu) 1998-03-30
CN1168679A (zh) 1997-12-24
NO972522L (no) 1997-08-06
WO1996017874A1 (en) 1996-06-13
PE52996A1 (es) 1996-12-12
BR9509902A (pt) 1997-10-21
EP0787151A1 (en) 1997-08-06
MA23739A1 (fr) 1996-07-01
FI972430A0 (fi) 1997-06-06
CO4480041A1 (es) 1997-07-09
JP2001506122A (ja) 2001-05-15
AU4256096A (en) 1996-06-26
CZ172497A3 (en) 1997-10-15
PL320610A1 (en) 1997-10-13
MX9704225A (es) 1997-09-30
ZA9510195B (en) 1996-06-07
IL116228A0 (en) 1996-03-31

Similar Documents

Publication Publication Date Title
NO955167D0 (no) Monoklonalt anti-
NL300163I2 (nl) Vermenselijkte anti-CD1 11a-antilichamen.
DE69920897D1 (de) Monoklonale antikörper mit verringerter immunisierungsfähigkeit
DE68914244T2 (de) Monoklonaler Antikörper.
CY2007012I2 (el) Αντισωματα anti-vegf
DE3854502T2 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
DE69738312D1 (de) Hepatitis b monoklonale antikörper
TR199501542A2 (tr) Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari.
TR199800517A3 (tr) Hümanize anti-hümen fas antikor.
TR199800604A3 (tr) Anti-fas antikorlari.
DE606516T1 (de) Gegen menschlichen Ceruloplasmin monoklonaler Antikörper.
NO890116D0 (no) Monoklonale antistoffer.
DE68912772T2 (de) Monoklonaler antikörper gegen entero-viren.
DE69023717T2 (de) Monoklonaler Antikörper.
IT8821702A0 (it) Nuovo anticorpo monoclonale.
FI893928A (fi) Monoklonala motkroppar.
ITRM920223A0 (it) Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf.
EP0654532A4 (en) ANTIMUCOGLYCOPROTEIN MONOCLONAL ANTIBODIES.
DE69020315D1 (de) Monoklonaler antikörper gegen c-reaktives protein.
BR1100555B1 (pt) anticorpos monoclonais humanizados.
BR9709080A (pt) Anticorpo monoclonal anti-MP52 humano
DE68916088T2 (de) Anti-CPBII-monoklonaler Antikörper.
ES1028491Y (es) Nueva cristalera atermana.
ES1029564Y (es) Reloj de pulsera.
BR1100504A (pt) anticorpos anti-ige.